Your medicine may have the power to fight cancer

Repurposing the drugs can be the biggest revolution that is about to hit the market, although the doctors can use the drugs approved for a particular disease to treat another disease many prefer not approving this because the label of the medicine doesn’t mention it. But all of this could change as Metformin, most prescribed medicine worldwide for diabetic patients might have more to it than just control diabetes. A 2005 research in Scotland shows that people hooked to Metformin were 23 percent less probable to get cancer, hinting to the fact that it might also prevent cancer.

Numerous studies are ongoing to find out metformin’s ability to fight cancer, while there are a few types of research going on to find out if metformin combined with therapy can cure or fight cancer. It is a very well-known fact that developing a new drug can be very time consuming and extremely expensive, thus various organizations and individual researchers are going back to the basics and returning with extraordinary attempts and discoveries with drug repurposing, this is regarded as the best way to present patients with new, quick and affordable treatments to the patients.

In the pharmaceutical world, it is a very well-known fact that repurposing is the major part of the future in medication, the experts have also stated it is impossible to go for a medical conference without the talks of repurposing. The concept of repurposing has a very good precedent set to it, Viagra, which is today considered as a key medicine to fight sexual inadequacy was actually repurposed twice, the medicine was originally designed to fight hypertension, after research it was deemed to be the ideal medicine to help people suffering from angina, and it finally reached its treatment of sexual diseases stage when few male volunteers who registered in trials experienced side-effects that implied at a likelihood of using it to treat sexual difficulties.

Companies, however, do not put in extra efforts or resources in the research for redevelopment because, by the time results are out, the product is most probably out of patent, thus giving no or very low incentive to the parent company. Therefore from the historical precedents and the research, it is safe to assume the treatment of cancer may be lying somewhere close in your closet.

, , , , , , , , ,